170 related articles for article (PubMed ID: 19917065)
21. Different effects of compounds decreasing cholesteryl ester transfer protein activity on lipoprotein metabolism.
Niesor EJ
Curr Opin Lipidol; 2011 Aug; 22(4):288-95. PubMed ID: 21587074
[TBL] [Abstract][Full Text] [Related]
22. Spotlight on HDL-raising therapies: insights from the torcetrapib trials.
Kontush A; Guérin M; Chapman MJ
Nat Clin Pract Cardiovasc Med; 2008 Jun; 5(6):329-36. PubMed ID: 18431367
[TBL] [Abstract][Full Text] [Related]
23. Cardiovascular effects of torcetrapib in conscious and pentobarbital-anesthetized dogs.
Polakowski JS; King AJ; Campbell TJ; Nelson RA; Preusser LC; Kempf-Grote AJ; Marsh KC; Gintant GA; Cox BF; Mittelstadt SW
J Cardiovasc Pharmacol; 2009 Dec; 54(6):543-51. PubMed ID: 19770671
[TBL] [Abstract][Full Text] [Related]
24. Lack of effect of dalcetrapib on QT interval in healthy subjects following multiple dosing.
Derks M; Abt M; Mwangi A; Meneses-Lorente G
Eur J Clin Pharmacol; 2010 Aug; 66(8):775-83. PubMed ID: 20521033
[TBL] [Abstract][Full Text] [Related]
25. Cholesteryl ester transfer protein inhibitors as high-density lipoprotein raising agents.
Shinkai H
Expert Opin Ther Pat; 2009 Sep; 19(9):1229-37. PubMed ID: 19663630
[TBL] [Abstract][Full Text] [Related]
26. Cholesteryl ester transfer protein inhibitors: challenges and perspectives.
Filippatos TD; Klouras E; Barkas F; Elisaf M
Expert Rev Cardiovasc Ther; 2016 Aug; 14(8):953-62. PubMed ID: 27171534
[TBL] [Abstract][Full Text] [Related]
27. Persistent cardiovascular effects of chronic renin-angiotensin system inhibition following withdrawal in adult spontaneously hypertensive rats.
Paull JR; Widdop RE
J Hypertens; 2001 Aug; 19(8):1393-402. PubMed ID: 11518847
[TBL] [Abstract][Full Text] [Related]
28. Upregulation of the brain renin-angiotensin system in rats with chronic renal failure.
Nishimura M; Takahashi H; Yoshimura M
Acta Physiol (Oxf); 2007 Apr; 189(4):369-77. PubMed ID: 17367405
[TBL] [Abstract][Full Text] [Related]
29. Update on CETP inhibition.
Davidson MH
J Clin Lipidol; 2010; 4(5):394-8. PubMed ID: 21122682
[TBL] [Abstract][Full Text] [Related]
30. Standardized ethanol-water extract of Ficus deltoidea Angustifolia reduces blood pressure in spontaneously hypertensive rats.
Kamal MSA; Ismail NH; Satar NA; Azis NA; Radjeni Z; Mohammad Noor HS; Kasim N; Singh H
Clin Exp Hypertens; 2019; 41(5):444-451. PubMed ID: 30648895
[TBL] [Abstract][Full Text] [Related]
31. Safety of CETP inhibition.
Duivenvoorden R; Fayad ZA
Curr Opin Lipidol; 2012 Dec; 23(6):518-24. PubMed ID: 23010697
[TBL] [Abstract][Full Text] [Related]
32. Torcetrapib produces endothelial dysfunction independent of cholesteryl ester transfer protein inhibition.
Connelly MA; Parry TJ; Giardino EC; Huang Z; Cheung WM; Chen C; Cools F; Van der Linde H; Gallacher DJ; Kuo GH; Sarich TC; Demarest KT; Damiano BP
J Cardiovasc Pharmacol; 2010 May; 55(5):459-68. PubMed ID: 20051879
[TBL] [Abstract][Full Text] [Related]
33. Dalcetrapib , a cholesteryl ester transfer protein modulator.
Hooper AJ; Burnett JR
Expert Opin Investig Drugs; 2012 Sep; 21(9):1427-32. PubMed ID: 22725099
[TBL] [Abstract][Full Text] [Related]
34. Effects of dalcetrapib in patients with a recent acute coronary syndrome.
Schwartz GG; Olsson AG; Abt M; Ballantyne CM; Barter PJ; Brumm J; Chaitman BR; Holme IM; Kallend D; Leiter LA; Leitersdorf E; McMurray JJ; Mundl H; Nicholls SJ; Shah PK; Tardif JC; Wright RS;
N Engl J Med; 2012 Nov; 367(22):2089-99. PubMed ID: 23126252
[TBL] [Abstract][Full Text] [Related]
35. The failure of torcetrapib: what have we learned?
Joy TR; Hegele RA
Br J Pharmacol; 2008 Aug; 154(7):1379-81. PubMed ID: 18536741
[TBL] [Abstract][Full Text] [Related]
36. Effect of inhibition of nitric oxide synthesis on the uptake of LDL and fibrinogen by arterial walls and other organs of the rat.
Cardona-Sanclemente LE; Born GV
Br J Pharmacol; 1995 Apr; 114(7):1490-4. PubMed ID: 7606353
[TBL] [Abstract][Full Text] [Related]
37. Hyperinsulinemic rats are normotensive but sensitized to angiotensin II.
Johansson ME; Andersson IJ; Alexanderson C; Skøtt O; Holmäng A; Bergström G
Am J Physiol Regul Integr Comp Physiol; 2008 Apr; 294(4):R1240-7. PubMed ID: 18216141
[TBL] [Abstract][Full Text] [Related]
38. Interactions of NADPH oxidase, renin-angiotensin-aldosterone system and reactive oxygen species in mequindox-mediated aldosterone secretion in Wistar rats.
Huang XJ; Wang X; Ihsan A; Liu Q; Xue XJ; Su SJ; Yang CH; Zhou W; Yuan ZH
Toxicol Lett; 2010 Oct; 198(2):112-8. PubMed ID: 20553828
[TBL] [Abstract][Full Text] [Related]
39. Regulation of the gene expression of type-1 angiotensin II receptor in spontaneously hypertensive rats.
Kitami Y; Okura T; Wakamiya R; Marumoto K; Iwata T; Hiwada K
Blood Press Suppl; 1992; 3():12-6. PubMed ID: 1343280
[TBL] [Abstract][Full Text] [Related]
40. Effects of an angiotensin-converting enzyme (ACE) inhibitor, SA446, on tissue ACE activity in normotensive, spontaneously hypertensive, and renal hypertensive rats.
Nakata K; Nishimura K; Takada T; Ikuse T; Yamauchi H; Iso T
J Cardiovasc Pharmacol; 1987 Mar; 9(3):305-10. PubMed ID: 2437397
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
